FIELD: medicine.
SUBSTANCE: present invention refers to biotechnology, more specifically to cyclic peptides of TNF, and can be used in medicine. The cyclic peptide consisting of CGQRETPEGAEAKPWYC is used to prepare a therapeutic agent for preventing or treating vascular complications in the patients suffering diabetes, including as a part of a pharmaceutical composition.
EFFECT: invention enables preventing the vascular complications in the patients with diabetes effectively, herewith inducing no TNF-mediated pro-inflammatory reaction.
8 cl, 5 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF NKG2D INHIBITORS FOR TREATING CARDIOVASCULAR AND METABOLIC DISEASES SUCH AS TYPE 2 DIABETES | 2010 |
|
RU2566264C2 |
| FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE | 2020 |
|
RU2804335C2 |
| LIPID RAFT MODULATION | 2007 |
|
RU2457853C2 |
| METHOD OF TREATING IL-1BETA-DEPENDENT DISEASES | 2007 |
|
RU2554747C9 |
| COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETIC PATIENTS | 2012 |
|
RU2650635C2 |
| PEPTIDE WITH ANTI-OBESITY AND ANTIDIABETIC EFFICACY AND USE THEREOF | 2017 |
|
RU2721426C1 |
| COMPOSITION CONTAINING PEPTIDE AND VIRUS NEURAMINIDASE INHIBITOR | 2011 |
|
RU2596785C2 |
| STIMULATOR OF PANCREATIC BETA-CELL REGENERATION AND INSULIN PRODUCTION IN PANCREATIC BETA-CELLS | 2006 |
|
RU2403058C2 |
| METHOD OF TREATING NEPHROPATHY | 2014 |
|
RU2718054C2 |
| USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2013 |
|
RU2672341C2 |
